Molecular Diversity of Gliomas: Epidemiology, Pathology and Genetic/Epigenetic Heterogeneity
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: 1 June 2025 | Viewed by 2247
Special Issue Editor
Interests: brain tumors; glioblastoma; diffuse midline glioma; genomics and molecular classification; signaling pathways; PTEN tumor suppressor; NHERF1; diagnostic markers; therapy targets; glioma epidemiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to bring together the latest molecular studies on diffuse glioma/glioblastoma diversity. We welcome papers defining the molecular epidemiology of gliomas in various ethnic populations, with the aim of covering various evolution paradigms explaining the generation of heterogeneity in gliomas, including interactions with microenvironment, correlations between pathology and genetic/epigenetic changes; new markers and technologies for tracing heterogeneity; and therapy approaches addressing heterogeneity in gliomas. Mechanistic and descriptive in-depth molecular studies on the spatiotemporal evolution of adult and pediatric diffuse gliomas, including multifocality, clonal selection, cell migration and metastasis, will also be considered for publication. Finally, studies generating models of heterogeneous gliomas in animal or organoid systems are highly encouraged.
Dr. Maria-Magdalena Georgescu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glioma molecular heterogeneity
- glioblastoma demographics
- glioma spatiotemporal evolution
- glioma genomics
- glioma epigenomics
- glioma pathology
- animal and organoid models of glioma heterogeneity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
